Corymbia terminalis
Corymbia terminalis · Accepted scientific name
Scientific literature: Very Sparse (3 studies) · ★☆☆☆☆
Corymbia terminalis is a botanical species that has garnered scientific interest due to its diverse pharmacological potential. Research indicates that various preparations, including methanolic kino extracts, crude aqueous extracts, and both hot and cold infusions, possess significant antimicrobial and antibacterial activities. These therapeutic effects are largely attributed to the presence of key chemical compounds such as catechin, farrerol, taxifolin, and aromadendrin. Furthermore, the plant's extracts demonstrate the ability to influence biological conditions related to IL-6 and IL-8. Understanding these chemical profiles and their preparations offers valuable insights into the plant's medicinal applications.
- Synonyms
- Corymbia Tumescens · Eucalyptus Terminalis · 6 more
- Common names
- Not available
- Family
- Myrtaceae
- Distribution
- Southern America
- Plant Parts
- Not available
Classification
Common Names
Corymbia terminalis is a distinctive tree species known by several different names depending on the region and botanical context. It is most frequently identified by its common names, Desert Bloodwood and Plains Bloodwood. In certain scientific or local circles, it may also be referred to as korymbia vrcholová. These various monikers highlight the plant's widespread presence across diverse landscapes. Understanding these different designations is essential for anyone studying the diverse nomenclature of this unique species.
Sources: Catalogue of Life (COL)
Synonyms
Corymbia terminalis is a botanical species that has been identified by several different scientific names throughout history. Due to evolving taxonomic classifications, it is formally recognized as a synonym of Corymbia tumescens. The plant is also closely linked to Eucalyptus centralis and Eucalyptus corymbosa var. terminalis within various botanical records. Furthermore, researchers have previously categorized this species under the names Eucalyptus orientalis and Eucalyptus pyrophora. Understanding these overlapping relationships is essential for maintaining accuracy in modern plant identification and documentation.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Corymbia terminalis belongs to the diverse kingdom Plantae, representing a fascinating branch of the natural world. Within this kingdom, the species is classified under the class Equisetopsida. It further falls into the order Myrtales, a group that shares many distinct botanical characteristics. As a member of the Myrtaceae family, it showcases the unique traits typical of its relatives. Ultimately, this plant is defined by its placement within the genus Corymbia.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Myrtales |
| Family | Myrtaceae |
| Genus | Corymbia |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Corymbia terminalis is a notable plant species widely distributed across the Australasia region. Within Australia, its presence is extensively recorded across several diverse states. It can be found growing in the landscapes of New South Wales, the Northern Territory, and Queensland. Furthermore, the species extends its reach into the southern and western reaches of the continent, inhabiting South Australia and Western Australia. This broad geographic range highlights the adaptability of the species to various Australian environments.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Corymbia terminalis is a self-supporting species characterized by its distinct tree growth form. This plant typically reaches a maximum height of 15 meters as it matures in its natural habitat. While it can be found at a minimum height of only 3 meters in some stages, most established specimens stand much taller. Generally, the height of a healthy individual will be at least 12 meters. This range of size allows the species to maintain a prominent presence within its ecosystem.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Corymbia terminalis, a member of the Myrtaceae family, possesses significant medicinal potential through its red resin known as kino. Recent scientific evaluations have confirmed that this plant exhibits potent antimicrobial activity against various bacterial strains. Specifically, research into its flavonoid content shows that compounds like farrerol and catechin provide strong antibacterial effects. Studies involving wound-associated pathogens demonstrate that both organic solvent extracts and traditional water-based infusions can effectively inhibit bacterial growth. These findings validate the ethnopharmacological use of C. terminalis in Indigenous Australian medicine and highlight its promise as a natural therapeutic agent.
Compounds
Corymbia terminalis is a member of the Myrtaceae family that has long been recognized for its various medicinal applications. Recent research into its red exudate, or kino, has successfully identified four major bioactive flavonoids within the plant. Specifically, the study isolated catechin, farrerol, taxifolin, and aromadendrin from the specimen. These chemical constituents demonstrated significant antimicrobial and anti-inflammatory properties during pharmacological testing. Ultimately, these findings validate the traditional use of the plant and highlight its potential as a valuable therapeutic source.
Conditions
Corymbia terminalis kino extracts demonstrate significant biological activity by modulating key inflammatory markers, including the biphasic modulation of IL-6. The extracts also achieve a significant downregulation of IL-8 within human keratinocytes. Furthermore, the plant exhibits medicinal potential through the inhibition of cyclooxygenase (COX-1/COX-2) enzymes. These actions contribute to a marked reduction in the overall inflammatory response. Additionally, the extracts exert cytoregulatory effects by suppressing keratinocyte proliferation in a dose-dependent manner.
Preparations
Corymbia terminalis produces a reddish exudate known as kino, which has long been utilized in Indigenous Australian medicine. This substance can be prepared as various methanolic kino extracts to evaluate its cytoregulatory and anti-inflammatory properties. Researchers also utilize crude aqueous extracts to assess the plant's biological activity against wound-associated pathogens. Furthermore, the kino can be processed through hot/cold infusion methods, which demonstrate that certain active antimicrobial compounds are thermostable. Ultimately, these diverse preparation methods, including various kino extracts, highlight the therapeutic versatility of the species.